Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival
Open accessThe DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Colony-stimulating factor 1 (CSF1) and interleukin-34 (IL-34) are functional ligands of the CSF1 receptor (CSF1R) and thus are key regulators of the monocyte/macrophage lineage. We discovered that systemic administration of human recombinant CSF1 ameliorates memory deficits in a transgenic mouse model of Alzheimer’s disease. CSF1 and IL-34 strongly reduced excitotoxin-induced neuronal cell loss and gliosis in wild-type mice when administered systemically before or up to 6 h after injury. These effects were accompanied by maintenance of cAMP responsive element–binding protein (CREB) signaling in neurons rather than in microglia. Using lineage-tracing experiments, we discovered that a small number of neurons in the hippocampus and cortex express CSF1R under physiological conditions and that kainic acid–induced excitotoxic injury results in a profound increase in neuronal receptor expression. Selective deletion of CSF1R in forebrain neurons in mice exacerbated excitotoxin-induced death and neurodegeneration. We conclude that CSF1 and IL-34 provide powerful neuroprotective and survival signals in brain injury and neurodegeneration involving CSF1R expression on neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







![Figure 8. CSF1 maintains CREB phosphorylation. (A–D) CSF1 maintains CREB phosphorylation after KA lesion. Wild-type FVB/N mice (n = 4 per group, 2 mo of age) were lesioned with 20 mg/kg KA (subcutaneous injection) or injected with PBS as control. For treatment, CSF1 or PBS was applied 24 h before KA. Mice were sacrificed 6 h after KA injection. One hemibrain was fixed for immunohistochemistry with an antibody against p-CREB (A, left and middle), and p-CREB immunoreactivity was quantified as percentage of area occupied (B). The opposite hippocampi were isolated and subjected to Western blot analysis for p-CREB (C), which was quantified as optical intensity (D). Results are from one out of two independent experiments. (E and F) CSF1 restores CREB signaling in hAPP mice. hAPP mice and their nTG littermates (Fig. 1 A) were treated with 800 µg/kg CSF1 or PBS three times a week. 10 wk later, the mice were sacrificed after water maze behavior test, and one hemibrain was analyzed by immunohistochemistry for p-CREB immunoreactivity. The experiment was performed once. Error bars indicate SEM. Bars: (A, left) 200 µm; (A [middle and right] and E) 50 µm. *, P < 0.05; **, P < 0.01 compared by ANOVA and Bonferroni post-hoc test (B and F) or Student’s t test (D).](https://figures.cochat.ai/paper-figures/c0d130c8f62e426fa46ee8a529a15acf/colony-stimulating-factor-1-receptor-csf1r-signaling-in-injured-neurons-figure-8.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“studies in mouse models suggest that CSF1R ligands, such as IL-34 and CSF1, may provide neuroprotective and survival signals in neurodegeneration by activating CSF1R on selected neuron populations rather than microglia (194).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [194]
Experimental — accuracy not yet measuredIn the citing paper
“CSF1R signaling in a selected neuron population, rather than in microglia, provides neuroprotective and survival signals in the neurodegeneration setting (146).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [146]
In the citing paper
“the MD5828- specific metagene for factor 5, which was microglia-specific, had high loadings of TMSB4X and CSF1R, both of which play important roles in the acute response to TBI (Luo et al., 2013; Xiong et al., 2012).”
From Single-Cell Multi-omic Integration Compares and Contrasts Features of Brain Cell Identity (2019) · cites this paper as Luo et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Penkowa, M., Poulsen, C. B., Carrasco, J., & Hidalgo, J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7968 · Cited by 20
RetractedFate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917
A global double-fluorescent Cre reporter mouse
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., & Luo, L. (2007) · genesis · doi:10.1002/dvg.20335 · Cited by 3,491
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
‘Green mice’ as a source of ubiquitous green cells
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., & Nishimune, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00313-x · Cited by 2,581 · cited 3×
“The following transgenic mouse lines were used: hAPP mice (line 41) expressing mutated (London V717I and Swedish K670M/N671L) human APP751 under the control of the mouse Thy1 promoter (Rockenstein et al., 2001), GFAP-luc mice (Caliper Life Science; Zhu et al., 2004), CSF1-null Csf1op/Csf1op mice (The Jackson Laborator…”
BackgroundMethodFunction and regulation of CREB family transcription factors in the nervous system
Lonze, B. E., & Ginty, D. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00828-0 · Cited by 2,127
Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789
The ageing systemic milieu negatively regulates neurogenesis and cognitive function
Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., Stan, T. M., Fainberg, N., Ding, Z., Eggel, A., et al. (2011) · Nature · doi:10.1038/nature10357 · Cited by 1,763
Self-citation
Cited by
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Therapeutic Targeting of the Tumor Microenvironment
Bejarano, L., Jordāo, M. J. C., & Joyce, J. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1808 · Cited by 1,653
Single-Cell Multi-omic Integration Compares and Contrasts Features of Brain Cell Identity
Welch, J. D., Kozareva, V., Ferreira, A., Vanderburg, C., Martin, C., & Macosko, E. Z. (2019) · Cell · doi:10.1016/j.cell.2019.05.006 · Cited by 1,193
Microglia in Alzheimer's disease
Sarlus, H., & Heneka, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90606 · Cited by 911
CSF-1 receptor signaling in myeloid cells.
Stanley, E. R., & Chitu, V. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021857 · Cited by 825
The Semantics of Microglia Activation: Neuroinflammation, Homeostasis, and Stress
Woodburn, S. C., Bollinger, J. L., & Wohleb, E. S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02309-6 · Cited by 783
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Mechanisms of Organ Injury and Repair by Macrophages
Vannella, K. M., & Wynn, T. A. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034356 · Cited by 656
Szalay, G., Martinecz, B., Lénárt, N., Környei, Z., Orsolits, B., Judák, L., Császár, E., Fekete, R., West, B. L., Katona, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms11499 · Cited by 573
Ushach, I., & Zlotnik, A. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0316-144r · Cited by 551
Microglial subtypes: diversity within the microglial community
Stratoulias, V., Venero, J. L., Tremblay, M., & Joseph, B. (2019) · The EMBO Journal · doi:10.15252/embj.2019101997 · Cited by 547
Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model
Shi, Y., Manis, M., Long, J., Wang, K., Sullivan, P. M., Remolina Serrano, J., Hoyle, R., & Holtzman, D. M. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20190980 · Cited by 448
Sosna, J., Philipp, S., Albay, R., Reyes-Ruiz, J. M., Baglietto-Vargas, D., LaFerla, F. M., & Glabe, C. G. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0244-x · Cited by 406
“A study by Luo and coworkers reported that CSF1 ameliorated memory deficits in the hAPP mouse model and CSF1 and IL34 administration strongly reduced excitotoxic neuronal loss, while deletion of CSF1R in neurons exacerbated excitotoxic neuronal death [25].”
BackgroundOntogeny and homeostasis of CNS myeloid cells
Prinz, M., Erny, D., & Hagemeyer, N. (2017) · Nature Immunology · doi:10.1038/ni.3703 · Cited by 392
Emerging Roles for CSF-1 Receptor and its Ligands in the Nervous System
Chitu, V., Gokhan, Ş., Nandi, S., Mehler, M. F., & Stanley, E. R. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.03.005 · Cited by 362
Depletion of microglia exacerbates postischemic inflammation and brain injury
Jin, W.-N., Shi, S. X.-Y., Li, Z., Li, M., Wood, K., Gonzales, R. J., & Liu, Q. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17694185 · Cited by 351
“However, accumulating evidence shows that elimination of microglia had no discernable impact on neurological function and baseline brain inflammatory status under physiological conditions.(65,66) In agreement with these findings, we found that PLX3397 treatment does not alter inflammation status, and only has minimal…”
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
de Rojas, I., Moreno-Grau, S., Tesi, N., Grenier-Boley, B., Andrade, V., Jansen, I. E., Pedersen, N. L., Stringa, N., Zettergren, A., Hernández, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22491-8 · Cited by 324
TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway
Zheng, H., Jia, L., Liu, C.-C., Rong, Z., Zhong, L., Yang, L., Chen, X.-F., Fryer, J. D., Wang, X., Zhang, Y.-W., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2459-16.2017 · Cited by 317
TREM2 regulates microglial cell activation in response to demyelination in vivo
Cantoni, C., Bollman, B., Licastro, D., Xie, M., Mikesell, R., Schmidt, R., Yuede, C. M., Galimberti, D., Olivecrona, G., Klein, R. S., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1388-1 · Cited by 296
“Notably, treatment with CSF-1 or IL-34, which increases microglia numbers and internalization of β-amyloid, leads to reduction of amyloid deposition and amelioration of memory deficits in transgenic AD mouse models [4, 42, 49].”
Wohleb, E. S., Terwilliger, R., Duman, C. H., & Duman, R. S. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.026 · Cited by 288
Kierdorf, K., & Prinz, M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90602 · Cited by 285
Oosterhof, N., Chang, I. J., Karimiani, E. G., Kuil, L. E., Jensen, D. M., Daza, R., Young, E., Astle, L., van der Linde, H. C., Shivaram, G. M., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.03.010 · Cited by 247
Goshi, N., Morgan, R. K., Lein, P. J., & Seker, E. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01819-z · Cited by 242
Neural progenitor cells orchestrate microglia migration and positioning into the developing cortex
Arnò, B., Grassivaro, F., Rossi, C., Bergamaschi, A., Castiglioni, V., Furlan, R., Greter, M., Favaro, R., Comi, G., Becher, B., et al. (2014) · Nature Communications · doi:10.1038/ncomms6611 · Cited by 236
Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration
Pluvinage, J. V., & Wyss-Coray, T. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0255-9 · Cited by 191
Self-citationOosterhof, N., Kuil, L. E., van der Linde, H. C., Burm, S. M., Berdowski, W., van Ijcken, W. F. J., van Swieten, J. C., Hol, E. M., Verheijen, M. H. G., & van Ham, T. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.113 · Cited by 178
“Even though low expression of Csf1r has been reported in some neurons in the hippocampus, the expression of CSF1R is almost exclusive to microglia, suggesting that ALSP pathogenesis involves microglia dysfunction (Luo et al., 2013).”
BackgroundLandel, V., Baranger, K., Virard, I., Loriod, B., Khrestchatisky, M., Rivera, S., Benech, P., & Féron, F. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-33 · Cited by 176
“Interestingly, Csf1r signaling in injured neurons facilitates protection and survival [139].”
Recent Advances in Biomarkers for Parkinson’s Disease
He, R., Yan, X., Guo, J., Xu, Q., Tang, B., & Sun, Q. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00305 · Cited by 175
Sehgal, A., Irvine, K. M., & Hume, D. A. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101509 · Cited by 174
Csf1R inhibition attenuates experimental autoimmune encephalomyelitis and promotes recovery
Nissen, J. C., Thompson, K. K., West, B. L., & Tsirka, S. E. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.05.021 · Cited by 168
Absence of microglia promotes diverse pathologies and early lethality in Alzheimer’s disease mice
Kiani Shabestari, S., Morabito, S., Danhash, E. P., McQuade, A., Sanchez, J. R., Miyoshi, E., Chadarevian, J. P., Claes, C., Coburn, M. A., Hasselmann, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110961 · Cited by 167
“One previous study reported that CSF1R may also be expressed in neurons (Luo et al., 2013), although a recently developed CSF1R-reporter model revealed no neuronal expression (Grabert et al., 2020).”
Interleukin-34, a comprehensive review
Baghdadi, M., Umeyama, Y., Hama, N., Kobayashi, T., Han, N., Wada, H., & Seino, K.-I. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr1117-457r · Cited by 163
Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor
Chitu, V., & Stanley, E. R. (2017) · Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.10.004 · Cited by 161
Han, J., Chitu, V., Stanley, E. R., Wszolek, Z. K., Karrenbauer, V. D., & Harris, R. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04225-1 · Cited by 161
Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases
Hamilton, J. A., Cook, A. D., & Tak, P. P. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.231 · Cited by 160
Perandini, L. A., Chimin, P., Lutkemeyer, D. D. S., & Câmara, N. O. S. (2018) · The FEBS Journal · doi:10.1111/febs.14417 · Cited by 159
Li, M., Li, Z., Ren, H., Jin, W.-N., Wood, K., Liu, Q., Sheth, K. N., & Shi, F.-D. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16666551 · Cited by 157
Preclinical Assessment of Young Blood Plasma for Alzheimer Disease
Middeldorp, J., Lehallier, B., Villeda, S. A., Miedema, S. S. M., Evans, E., Czirr, E., Zhang, H., Luo, J., Stan, T., Mosher, K. I., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.3185 · Cited by 153
Self-citationThe influence of environment and origin on brain resident macrophages and implications for therapy
Bennett, M. L., & Bennett, F. C. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0545-6 · Cited by 147
Luo, J., Nguyen, A., Villeda, S., Zhang, H., Ding, Z., Lindsey, D., Bieri, G., Castellano, J. M., Beaupre, G. S., & Wyss-Coray, T. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00012 · Cited by 136
Self-citationBeckmann, N., Giorgetti, E., Neuhaus, A., Zurbruegg, S., Accart, N., Smith, P., Perdoux, J., Perrot, L., Nash, M., Desrayaud, S., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0510-8 · Cited by 131
“Several groups have shown that inhibition of the CSF1R pathway is neuroprotective in different disease conditions like amyotrophic lateral sclerosis [30], Charcot-MarieTooth type 1 neuropathies [23], catatonia in psychiatric disorders [19] and Alzheimer’s disease [29, 36, 48] by reducing neuroinflammation/inflammation.”
Phenotypic impacts of CSF1R deficiencies in humans and model organisms
Hume, D. A., Caruso, M., Ferrari-Cestari, M., Summers, K. M., Pridans, C., & Irvine, K. M. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0519-143r · Cited by 128
Haploinsufficiency of CSF-1R and clinicopathologic characterization in patients with HDLS
Konno, T., Tada, M., Tada, M., Koyama, A., Nozaki, H., Harigaya, Y., Nishimiya, J., Matsunaga, A., Yoshikura, N., Ishihara, K., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000046 · Cited by 128
Sadasivan, S., Zanin, M., O’Brien, K., Schultz-Cherry, S., & Smeyne, R. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124047 · Cited by 125
Neal, M. L., Fleming, S. M., Budge, K. M., Boyle, A. M., Kim, C., Alam, G., Beier, E. E., Wu, L., & Richardson, J. R. (2020) · The FASEB Journal · doi:10.1096/fj.201900567rr · Cited by 123
Chitu, V., Gokhan, S., Gulinello, M., Branch, C. A., Patil, M., Basu, R., Stoddart, C., Mehler, M. F., & Stanley, E. R. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.001 · Cited by 119
Kremer, D., Gruchot, J., Weyers, V., Oldemeier, L., Göttle, P., Healy, L., Ho Jang, J., Kang T. Xu, Y., Volsko, C., Dutta, R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901283116 · Cited by 118
Genetic targeting of microglia
Wieghofer, P., Knobeloch, K.-P., & Prinz, M. (2015) · Glia · doi:10.1002/glia.22727 · Cited by 117
Grabert, K., Sehgal, A., Irvine, K. M., Wollscheid-Lengeling, E., Ozdemir, D. D., Stables, J., Luke, G. A., Ryan, M. D., Adamson, A., Humphreys, N. E., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000835 · Cited by 114
Immunoregulatory properties of the cytokine IL-34
Guillonneau, C., Bézie, S., & Anegon, I. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2482-4 · Cited by 112
“Indeed, systemic administration of IL-34 strongly reduced excitotoxininduced neuronal cell loss and gliosis in mice model of Alzheimer’s disease [92].”
BackgroundEmerging roles of IL-34 in health and disease
Lelios, I., Cansever, D., Utz, S. G., Mildenberger, W., Stifter, S. A., & Greter, M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190290 · Cited by 111
Microglial trogocytosis and the complement system regulate axonal pruning in vivo
Lim, T. K., & Ruthazer, E. S. (2021) · eLife · doi:10.7554/elife.62167 · Cited by 111
Microglia regulate hippocampal neurogenesis during chronic neurodegeneration
De Lucia, C., Rinchon, A., Olmos-Alonso, A., Riecken, K., Fehse, B., Boche, D., Perry, V. H., & Gomez-Nicola, D. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.001 · Cited by 110
“On the other hand, activation of microglia with an anti-inflammatory molecule, such as TGFb, increases NSCs proliferation (Mathieu et al., 2010).”
BackgroundResultInfluentialCharacterisation of a Novel Fc Conjugate of Macrophage Colony-stimulating Factor
Gow, D. J., Sauter, K. A., Pridans, C., Moffat, L., Sehgal, A., Stutchfield, B. M., Raza, S., Beard, P. M., Tsai, Y. T., Bainbridge, G., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.112 · Cited by 105
Okubo, M., Yamanaka, H., Kobayashi, K., Dai, Y., Kanda, H., Yagi, H., & Noguchi, K. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153375 · Cited by 105
Insights Into the Role of CSF1R in the Central Nervous System and Neurological Disorders
Hu, B., Duan, S., Wang, Z., Li, X., Zhou, Y., Zhang, X., Zhang, Y.-W., Xu, H., & Zheng, H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.789834 · Cited by 104
The Role of Microglia in Neuroinflammation of the Spinal Cord after Peripheral Nerve Injury
Pottorf, T. S., Rotterman, T. M., McCallum, W. M., Haley-Johnson, Z., & Álvarez, F. J. (2022) · Cells · doi:10.3390/cells11132083 · Cited by 103
Conedera, F. M., Pousa, A. M. Q., Mercader, N., Tschopp, M., & Enzmann, V. (2019) · Glia · doi:10.1002/glia.23601 · Cited by 104
Woodburn, S. C., Bollinger, J. L., & Wohleb, E. S. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100312 · Cited by 100
Pleiotropic effects of extended blockade of CSF1R signaling in adult mice
Sauter, K. A., Pridans, C., Sehgal, A., Tsai, Y. T., Bradford, B. M., Raza, S., Moffat, L., Gow, D. J., Beard, P. M., Mabbott, N. A., et al. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.2a0114-006r · Cited by 100
“Others have claimed that the CSF1R is expressed functionally in subsets of neurons [50] and in renal proximal tubule cells [51].”
BackgroundWang, Y., & Colonna, M. (2014) · European Journal of Immunology · doi:10.1002/eji.201344365 · Cited by 97
Carvalho, K., Faivre, E., Pietrowski, M. J., Marques, X., Gomez-Murcia, V., Deleau, A., Huin, V., Hansen, J. N., Kozlov, S., Danis, C., et al. (2019) · Brain · doi:10.1093/brain/awz288 · Cited by 92
Arreola, M. A., Soni, N., Crapser, J. D., Hohsfield, L. A., Elmore, M. R. P., Matheos, D. P., Wood, M. A., Swarup, V., Mortazavi, A., & Green, K. N. (2021) · Science Advances · doi:10.1126/sciadv.abg1601 · Cited by 91
Tesseur, I., Nguyen, A., Chang, B., Li, L., Woodling, N. S., Wyss-Coray, T., & Luo, J. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2952-16.2017 · Cited by 88
Self-citationTrías, E., Kovacs, M., King, P. H., Si, Y., Kwon, Y., Varela, V., Ibarburu, S., Moura, I. C., Hermine, O., Beckman, J. S., et al. (2019) · Glia · doi:10.1002/glia.23768 · Cited by 85
Adams, S., Kirk, A., & Auer, R. N. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.10.060 · Cited by 83
Interleukin 34, from pathogenesis to clinical applications
Baghdadi, M., Endo, H., Tanaka, Y., Wada, H., & Seino, K. (2017) · Cytokine · doi:10.1016/j.cyto.2017.08.020 · Cited by 81
CSF1 overexpression has pleiotropic effects on microglia in vivo
De, I., Nikodemova, M., Steffen, M. D., Sokn, E., Maklakova, V. I., Watters, J. J., & Collier, L. S. (2014) · Glia · doi:10.1002/glia.22717 · Cited by 79
Microglial Function and Regulation during Development, Homeostasis and Alzheimer’s Disease
Casali, B. T., & Reed-Geaghan, E. G. (2021) · Cells · doi:10.3390/cells10040957 · Cited by 78
Help-me signaling: Non-cell autonomous mechanisms of neuroprotection and neurorecovery
Xing, C., & Lo, E. H. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.004 · Cited by 76
Rivera-Escalera, F., Pinney, J. J., Owlett, L., Ahmed, H., Thakar, J., Olschowka, J. A., Elliott, M. R., & O’Banion, M. K. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1645-7 · Cited by 75
CSF1R mutations in hereditary diffuse leukoencephalopathy with spheroids are loss of function
Pridans, C., Sauter, K. A., Baer, K., Kissel, H., & Hume, D. A. (2013) · Scientific Reports · doi:10.1038/srep03013 · Cited by 74
Microglial Progranulin: Involvement in Alzheimer’s Disease and Neurodegenerative Diseases
Mendsaikhan, A., Tooyama, I., & Walker, D. G. (2019) · Cells · doi:10.3390/cells8030230 · Cited by 72
Du, X., Xu, Y., Chen, S., & Fang, M. (2020) · Neural Plasticity · doi:10.1155/2020/8825954 · Cited by 72
Essayan-Perez, S., & Südhof, T. C. (2023) · Neuron · doi:10.1016/j.neuron.2023.07.005 · Cited by 71
Tada, M., Konno, T., Tada, M., Tezuka, T., Miura, T., Mezaki, N., Okazaki, K., Arakawa, M., Itoh, K., Yamamoto, T., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24754 · Cited by 70
“A recent study of neuronal degeneration in mice has shown that CSF-1R is expressed in a subset of neurons, and that CSF-1 administration improves neuronal cell survival without significant microglial activation.(29) Another mouse study has also demonstrated that CSF1R is expressed in neuronal stem cells, and that the…”
BackgroundShi, M., Movius, J., Dator, R., Aro, P., Zhao, Y., Pan, C., Lin, X., Bammler, T. K., Stewart, T., Zabetian, C. P., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.040576 · Cited by 70
Attenuated CSF‐1R signalling drives cerebrovascular pathology
Delaney, C., Farrell, M., Doherty, C. P., Brennan, K., O’Keeffe, E., Greene, C., Byrne, K., Kelly, E., Birmingham, N., Hickey, P., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012889 · Cited by 69
Jin, S., Sonobe, Y., Kawanokuchi, J., Horiuchi, H., Cheng, Y. H., Wang, Y., Mizuno, T., Takeuchi, H., & Suzumura, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115981 · Cited by 68
Yadav, S., Priya, A., Borade, D. R., & Agrawal-Rajput, R. (2022) · Immunologic Research · doi:10.1007/s12026-022-09330-8 · Cited by 68
Sauter, K. A. D., Pridans, C., Sehgal, A., Bain, C. C., Scott, C. L., Moffat, L., Rojo, R., Stutchfield, B. M., Davies, C. L., Donaldson, D. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105429 · Cited by 67
Cid, E., Márquez-Galera, Á., Valero, M., Gal, B., Medeiros, D. D. C., Navarrón, C. M., Ballesteros-Esteban, L., Reig‐Viader, R., Morales, A. V., Fernández‐Lamo, I., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109229 · Cited by 66
Han, J., Sarlus, H., Wszolek, Z. K., Karrenbauer, V. D., & Harris, R. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01093-3 · Cited by 65
Zhou, X., Ji, B., Seki, C., Nagai, Y., Minamimoto, T., Fujinaga, M., Zhang, M., Saito, T., Saido, T. C., Suhara, T., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211004146 · Cited by 65
Genetic manipulation of microglia during brain development and disease
Wieghofer, P., & Prinz, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.019 · Cited by 61
Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented glia
Gelfand, J. M., Greenfield, A. L., Barkovich, M., Mendelsohn, B. A., Van Haren, K., Hess, C. P., & Mannis, G. N. (2020) · Brain · doi:10.1093/brain/awz390 · Cited by 61
Rojo, R., Pridans, C., Langlais, D., & Hume, D. A. (2017) · Clinical Science · doi:10.1042/cs20170238 · Cited by 60
Colony stimulating factors in the nervous system
Chiţu, V., Biundo, F., & Stanley, E. R. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101511 · Cited by 59
IL-34 and CSF-1, deciphering similarities and differences at steady state and in diseases
Freuchet, A., Salama, A., Remy, S., Guillonneau, C., & Anegón, I. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru1120-773r · Cited by 59
Gushchina, S., Pryce, G., Yip, P. K., Wu, D., Pallier, P., Giovannoni, G., Baker, D., & Bo, X. (2018) · Glia · doi:10.1002/glia.23464 · Cited by 55
Tian, L., Hui, C. W., Bisht, K., Tan, Y., Sharma, K. P., Chen, S., Zhang, X., & Tremblay, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.01.007 · Cited by 52
Azam, S., Haque, M. E., Kim, I., & Choi, D. (2021) · Cells · doi:10.3390/cells10010150 · Cited by 51
Sassi, C., Nalls, M. A., Ridge, P. G., Gibbs, J. R., Lupton, M. K., Troakes, C., Lunnon, K., Al-Sarraj, S., Brown, K. S., Medway, C., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.01.015 · Cited by 50
Biundo, F., Chiţu, V., Shlager, G. G. L., Park, E. S., Gulinello, M. E., Saha, K., Ketchum, H. C., Fernandes, C., Gökhan, Ş., Mehler, M. F., et al. (2020) · Glia · doi:10.1002/glia.23929 · Cited by 50
Hwang, D., Seyedsadr, M., Ishikawa, L. L. W., Boehm, A., Sahin, Z., Casella, G., Jang, S., Gonzalez, M. V., Garifallou, J. P., Hakonarson, H. H., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111804119 · Cited by 49
Modeling CSF‐1 receptor deficiency diseases – how close are we?
Chitu, V., Gökhan, Ş., & Stanley, E. R. (2022) · The FEBS Journal · doi:10.1111/febs.16085 · Cited by 49
Kelly, L., Seifi, M., Ma, R., Mitchell, S. J., Rudolph, U., Viola, K. L., Klein, W. L., Lambert, J. J., & Swinny, J. D. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12674 · Cited by 49
Sites of Cre-recombinase activity in mouse lines targeting skeletal cells
Couasnay, G., Madel, M., Lim, J., Lee, B., & Elefteriou, F. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4415 · Cited by 47
Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?
Geladaris, A., Häusler, D., & Weber, M. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073461 · Cited by 47
Metadata
- Authors
- Luo, J., Elwood, F., Britschgi, M., Villeda, S., Zhang, H., Ding, Z., Zhu, L., Alabsi, H., Getachew, R., Narasimhan, R., Wabl, R., Fainberg, N., James, M. L., Wong, G., Relton, J., Gambhir, S. S., Pollard, J. W., & Wyss-Coray, T.
- Affiliations
- Stanford Medicine (US)
- Albert Einstein College of Medicine (US)
- Biogen (United States) (US)
- Department of Neurology and Neurological Sciences 1 and 2
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2013-01-07
- Volume
- 210
- Issue
- 1
- Pages
- 157-172
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3549715
- OpenAlex
- W2171223421
- Cited by
- 262
- References
- 80
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 21 · 2023: 15 · 2022: 16 · 2021: 43 · 2020: 24 · 2019: 29 · 2018: 22 · 2017: 20 · 2016: 16 · 2015: 12 · 2014: 16 · 2013: 4
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc-sa)
- Funders
- Biogen
- National Institutes of Health
- National Institute on Aging (R21AG023708, AG20603, AG23708, R01AG020603)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- CSF-1 receptor, CSF-1, IL-34, neuroprotection, excitotoxicity, neurodegeneration, CREB signaling, hippocampus, cortex, gliosis, monocyte/macrophage lineage
- MeSH terms
- Animals, Base Sequence, Cell Survival, Cognition, Disease Models, Animal, Humans, Interleukins, Kainic Acid, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Neurons, Phosphorylation, Recombinant Proteins, Signal Transduction, Macrophage Colony-Stimulating Factor, Receptor, Macrophage Colony-Stimulating Factor, Prosencephalon, Amyloid beta-Protein Precursor, Cyclic AMP Response Element-Binding Protein, Neuroprotective Agents, Neurodegenerative Diseases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.